Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NARINASDAQ:UPST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNARIInari Medical$79.97$79.95$36.73▼$79.99$4.68B1.021.30 million shsN/AUPSTUpstart$43.14+20.2%$58.19$20.60▼$96.43$3.36B2.396.50 million shs12.80 million shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNARIInari Medical0.00%0.00%0.00%+0.84%+85.24%UPSTUpstart+20.20%-9.43%-8.99%-27.15%+64.22%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNARIInari Medical0.3604 of 5 stars1.10.00.00.00.62.50.6UPSTUpstart4.0114 of 5 stars4.12.00.02.71.43.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNARIInari Medical 2.14Hold$68.00-14.97% DownsideUPSTUpstart 2.21Hold$73.3870.11% UpsideCurrent Analyst Ratings BreakdownLatest UPST and NARI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/18/2025UPSTUpstartBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$80.00 ➝ $93.002/14/2025UPSTUpstartMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$12.00 ➝ $70.002/13/2025UPSTUpstartCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$87.00 ➝ $108.002/12/2025UPSTUpstartThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSell ➝ Sell$13.50 ➝ $15.002/12/2025UPSTUpstartBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$33.00 ➝ $39.002/12/2025UPSTUpstartPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$85.00 ➝ $105.002/12/2025UPSTUpstartNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$100.00 ➝ $108.002/12/2025UPSTUpstartJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Neutral$57.00 ➝ $79.002/12/2025UPSTUpstartB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$49.00 ➝ $105.00(Data available from 4/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNARIInari Medical$493.63M9.48$0.09 per share906.95$8.07 per share9.91UPSTUpstart$628.83M6.43N/AN/A$6.76 per share6.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNARIInari Medical-$1.64M-$1.35N/A727.00N/A-13.68%-10.09%-6.60%4/28/2025 (Estimated)UPSTUpstart-$128.58M-$1.46N/A46.39N/A-20.20%-25.87%-7.95%5/6/2025 (Estimated)Latest UPST and NARI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/6/2025Q1 2025UPSTUpstart$0.19N/AN/AN/A$201.08 millionN/A2/11/2025Q4 2024UPSTUpstart-$0.04-$0.02+$0.02-$0.03$182.00 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNARIInari MedicalN/AN/AN/AN/AN/AUPSTUpstartN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNARIInari MedicalN/A1.771.40UPSTUpstartN/A0.600.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNARIInari Medical90.98%UPSTUpstart63.01%Insider OwnershipCompanyInsider OwnershipNARIInari Medical10.60%UPSTUpstart18.06%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNARIInari Medical80058.54 million52.34 millionOptionableUPSTUpstart1,88093.71 million76.79 millionOptionableUPST and NARI HeadlinesRecent News About These CompaniesShould You Buy Upstart During the Stock Market Sell-Off?April 10 at 5:00 AM | fool.comUpstart vs. SoFi: Which Fintech Stock is the Smarter Buy Today?April 9 at 4:00 PM | zacks.comUpstart (UPST) Soars 8.6%: Is Further Upside Left in the Stock?April 8 at 7:15 AM | zacks.comUpstart to Announce First Quarter 2025 Results on May 6, 2025April 7 at 4:05 PM | businesswire.comUpstart Holdings, Inc. (UPST) Stock Slides as Market Rises: Facts to Know Before You TradeApril 1, 2025 | zacks.comNewtekOne: 6.4% Dividend Yield From Banking Upstart Is ElevatedMarch 31, 2025 | seekingalpha.comUpstart: Looking For The Buy ZoneMarch 30, 2025 | seekingalpha.comUpstart: One Meme Stock Worth Buying Amidst The Chaos (Rating Upgrade)March 28, 2025 | seekingalpha.comUpstart Consumer Brands Are Challenging Food GiantsMarch 28, 2025 | marketwatch.comHere is What to Know Beyond Why Upstart Holdings, Inc. (UPST) is a Trending StockMarch 27, 2025 | zacks.comUpstart Stock Dips 10% YTD: Is It a Golden Buying Opportunity?March 25, 2025 | zacks.comNasdaq Correction: 2 AI Stocks Down 33% and 86% to Buy Before They Soar, According to Wall StreetMarch 25, 2025 | fool.com2 Monster Stocks to Hold for the Next 5 YearsMarch 24, 2025 | fool.comBuy 5 AI-Powered Non-Tech Stocks to Tap Massive Short-Term PotentialMarch 13, 2025 | zacks.comThis Stock Dropped 47% in the Past 4 Weeks and Could Be a No-Brainer Buy During the Nasdaq CorrectionMarch 11, 2025 | fool.com3 Scorching-Hot Artificial Intelligence (AI) Stocks With 95% to 167% Upside, According to Select Wall Street AnalystsMarch 11, 2025 | fool.comUpstart Holdings, Inc. (UPST) The Citizens JMP Technology Conference (Transcript)March 3, 2025 | seekingalpha.com3 Tech Stocks I'm Buying if the Nasdaq Enters a CorrectionMarch 2, 2025 | fool.comEvaluating Upstart: A Cautious Path To Investment In Uncertain TimesFebruary 28, 2025 | seekingalpha.comHas Upstart (UPST) Outpaced Other Finance Stocks This Year?February 26, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUPST and NARI Company DescriptionsInari Medical NASDAQ:NARI$79.97 0.00 (0.00%) As of 02/19/2025Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Upstart NASDAQ:UPST$43.14 +7.25 (+20.20%) Closing price 04/9/2025 04:00 PM EasternExtended Trading$42.12 -1.02 (-2.36%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Upstart Holdings, Inc., together with its subsidiaries, operates a cloud-based artificial intelligence (AI) lending platform in the United States. Its platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small dollar loans that connects consumer demand for loans to its to bank and credit unions. Upstart Holdings, Inc. was founded in 2012 and is headquartered in San Mateo, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Alphabet a Generational Buying Opportunity at These Levels? Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop? Harley-Davidson Tops Watchlists: Value Trap or Turnaround Play? Strategy’s $5 Million Bitcoin Target: Beacon or Bagholder? Amazon Stock Bounces From Lows as Smart Money Steps In Qualcomm Breaks Down But RSI Signals It’s Severely Oversold Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy Will CrowdStrike's Goodwill Strategy Pay Off in Revenue Gains? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
